返回
Early commitment facilitates optimal choice by pigeons
DOI:10.3758/s13423-016-1173-8.png)
摘要
En 中文
Prior commitment has been found to facilitate choice of a larger later reward (e.g., healthy living) and avoid the impulsive choice of the smaller immediate reward (e.g., smoking, drug taking). In this research with pigeons, we investigated the ephemeral choice task in which pigeons are given a choice between two alternatives, A and B, with similar reinforcement provided for each; however, if they choose A, they can also choose B, whereas if they choose B, A is removed. Thus, choosing A gives them two rewards, whereas choosing B gives them only one. Paradoxically, pigeons actually show a preference for B, the suboptimal alternative. We tested the hypothesis that pigeons made suboptimal choices because they were impulsive. To reduce impulsivity, we required the pigeons to make their initial choice 20 s before receiving the first reward. We found that requiring the pigeons to make a prior commitment encouraged them to choose optimally. The control group, for which the reward was provided immediately following initial choice, continued to choose suboptimally. The results confirm that requiring animals to make a prior commitment can facilitate the development of optimal choice. Furthermore, they may help explain why, without prior commitment, impulsive species, such as primates and pigeons have difficulty with this task, whereas presumably less impulsive species, such as wrasse fish and under some conditions parrots, are able to choose optimally even without prior commitment.
Keyword:
Ephemeral choice task
Suboptimal choice
Prior commitment
Pigeons
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
P
IF:
3
论文数:
4.5K
被引数:
1.5W
机构
引用论文
Predictors of successful and unsuccessful quit attempts among smokers motivated to quit
ADDICTIVE BEHAVIORS
IF3.6
Experimental evidence that partner choice is a driving force in the payoff distribution among cooperators or mutualists: the cleaner fish case
Ecology Letters
IF7.9
Evaluating the Characteristics and the Management of Patients With Neuroendocrine Tumors Receiving Octreotide LAR During a 6-Year Period
Pancreas
IF0

